Healthcare & Life Sciences
Numab Therapeutics
Switzerlandnumab.com
Numab Therapeutics is a series b startup. 1 investor tracked. Status: possibledead.
unknownseries-b
series-b
Stage
3
Investors
About Numab Therapeutics
Based in Switzerland, Numab Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Numab Therapeutics is a biopharmaceutical company discovering and developing a new class of antibody therapeutics.
Explore Numab Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.